PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024.
Learn more - Pharmac announcement
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
PE/Dazzle™ 594 anti-human TCR Vα24-Jα18 (iNKT cell), 100 tests
PE/Dazzle™ 594 anti-human TCR Vα24-Jα18 (iNKT cell), 25 tests
PE/Dazzle™ 594 anti-human TCR Vα7.2, 100 tests
PE/Dazzle™ 594 anti-human TCR Vα7.2, 25 tests
PE/Dazzle™ 594 anti-human TCR α/β, 100 tests
PE/Dazzle™ 594 anti-human TCR α/β, 25 tests
PE/Dazzle™ 594 anti-human TCR γ/δ, 100 tests
PE/Dazzle™ 594 anti-human TCR γ/δ, 25 tests
PE/Dazzle™ 594 anti-human TIGIT (VSTM3), 100 tests
PE/Dazzle™ 594 anti-human TIGIT (VSTM3), 25 tests
PE/Dazzle™ 594 anti-human β2-microglobulin, 100 tests
PE/Dazzle™ 594 anti-human β2-microglobulin, 25 tests
PE/Dazzle™ 594 anti-human/mouse Bcl-6, 100 tests
PE/Dazzle™ 594 anti-human/mouse Bcl-6, 25 tests
PE/Dazzle™ 594 anti-human/mouse CD49f, 100 tests
PE/Dazzle™ 594 anti-human/mouse CD49f, 25 tests